Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 10:46 PM
Ignite Modification Date:
2025-12-24 @ 10:46 PM
NCT ID:
NCT00518869
Eligibility Criteria:
Inclusion Criteria:
* Signed the informed consent form.
* 18 \~ 75 years old
* Locally advanced or metastatic with inoperable stage IIIb-IV non-small-cell lung cancer.
* Chemo/Radio naive patient
* Karnofsky Performance Scores ≧ 70.
* Adequate bone marrow reserve.
* Adequate liver function.
* Adequate renal function.
* Women with childbearing potential are willing to take contraception measures through the whole treatment course.
* Life expectancy ≧ 3 months
* Patient must be willing and able to complete quality of life questionnaires.
Exclusion Criteria:
* Female patients are pregnant or breast-feeding
* Patients have brain metastases, stroke or major psychiatric disease.
* Patients with uncontrolled systemic disease such as active infection, severe heart disease, uncontrollable hypertension or diabetes mellitus.
* Patients have enrolled or have not yet completed other investigational drug trials within 30 days before randomization.
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
17 Years
Maximum Age:
75 Years
Study:
NCT00518869
Study Brief:
Protocol Section:
NCT00518869